AAO-HNS Participated in FDA Workshop on Sleep Devices
On April 16, 2018, the U.S. Food and Drug Administration (FDA) convened a public workshop at its Silver Spring, MD, campus regarding the regulation of medical devices for sleep disordered breathing. The FDA’s goal for the workshop was to expedite innovation and patient access to sleep apnea devices.
The AAO-HNS was invited by the FDA to serve as a key participant in the planning of the workshop, joining other clinicians, device manufacturers, patients, and stakeholders. In addition, several AAO-HNS physician leaders, including Kathleen Yaremchuk, MD, MSA, (task force chair); Raj Dedhia, MD; James C. Denneny III, MD; M. Boyd Gillespie, MD, MSc; Stacey L. Ishman, MD, MPH; Ofer Jacobowitz, MD, PhD; and Edward M. Weaver, MD, MPH; will participate as speakers and panel members at the meeting.
A recorded webcast is available on the FDA page.